Replacement of traditional solvents with ''environmentally benign'' ca
rbon dioxide is receiving increased attention in pharmaceutical proces
sing. Among the reported applications, particle formation with dense c
arbon dioxide and the ''clean'' synthesis of drug compounds using carb
on dioxide as a reaction medium hold immense potential for large-scale
application in the pharmaceutical industry. This paper provides-an ov
erview of these rapidly emerging technologies along with examples of t
he wide variety of relatively contaminant-free pharmaceutical compound
s that have been processed via these technologies on a laboratory scal
e. Challenges facing successful implementation in practice include dem
onstration of continuous production' and harvesting of particles with
desired and reproducible product characteristics. Mathematical models
aimed at a better fundamental understanding of the underlying thermoph
ysical phenomena are essential for rational design and scale-up of the
se technologies.